UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
Current Report
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): May 1, 2013
ProUroCare Medical Inc.
(Exact Name of Registrant as Specified in its Charter)
Nevada | 000-51774 | 20-1212923 |
(State or other jurisdiction | (Commission | (IRS Employer |
of incorporation) | File Number) | Identification No.) |
6440 Flying Cloud Dr., Suite 101, Eden Prairie, Minnesota 55344 | ||
(Address of Principal Executive Offices) (Zip Code) | ||
(952) 476-9093 | ||
(Registrant’s Telephone Number, Including Area Code) | ||
Not Applicable | ||
(Former Name or Former Address, if Changed Since Last Report) | ||
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| ||
¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | ||
¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | ||
¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | ||
¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 8.01 Other Events
On May 1, 2012, ProUroCare Medical posted on its website (www.prourocare.com) a letter to shareholders from its interim CEO, Stan Myrum describing the Company’s plans for the future.
A copy of the letter is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference herein.
Item 9.01 Financial Statements and Exhibits
a) Not applicable.
b) Not applicable.
c) Not applicable.
d) Exhibits
Exhibit No. | Exhibit |
99.1 | Letter to ProUroCare shareholders dated May 1, 2013 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report on Form 8-K to be signed on its behalf by the undersigned hereunto duly authorized.
ProUroCare Medical Inc. | |||
Date: May 1, 2013 | By | /s/ Stan Myrum | |
Stan Myrum | |||
Interim Chief Executive Officer |